STANDARD BIOTOOLS INC. — Director's Dealing 2022

Jun 18, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2022-06-15

Reporting Person: Madaus Martin D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-15	Common Stock	A	30914	—	Acquired	46766	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-15	Stock Option (Right to Buy)	$1.86	A	42571	Acquired	2032-06-15	Common Stock (42571.0)	Direct

Footnotes

F1: Represents Restricted Stock Units that vest in full on the earlier to occur of June 15, 2023 and one day prior to the date of the Issuer's next annual meeting of stockholders.

F2: The Option becomes exercisable in twelve equal monthly increments beginning on July 15, 2022.